Bayer HealthCare Licenses MedScan™ Text-to-Knowledge Suite by Ariadne Genomics
Ariadne Genomics, Inc. today announced that Bayer HealthCare AG has licensed its MedScan™ Text-to-Knowledge Suite for development of an internal molecular interaction database. MedScan extracts pathway-related facts from scientific literature with state-of-the-art natural language processing technology.
“MedScan is high performance tool for automated extraction of pathway-related information from TXT, HTML, PDF and MS Office files; catalogs and archives. Extracted facts, ranging from regulation, expression or binding to molecular transport, protein modification and molecular synthesis are stored in XML files”, said Nikolai Daraselia, Director of Research at Ariadne Genomics. “MedScan easily integrates with other bioinformatics software, and can be configured for automatic daily activity, for example, PubMed updates processing.”
“Bayer HealthCare recognizes the importance of using pathway analysis tools for interpretation of experimental results and hypotheses validation. But to make these tools truly efficient, we need an internal integrated database of pathways and molecular networks, containing all most recent information”, said Michael Seewald, Bioinformatician at Bayer HealthCare AG. “We have chosen MedScan for its advanced natural language processing algorithm, well known for high recovery rate and accuracy, and its ease of integration with our bioinformatics systems.”
For more information about MedScan Text-to-Knowledge Suite, or for a web-based trial, click here.
About Ariadne Genomics
Ariadne Genomics develops systems biology tools for life science research: PathwayStudio® Central client-server and PathwayAssist™ desktop pathway analysis software; MedScan™ Text-to-Knowledge Suite, an automated scientific text processing tool; ResNet™ molecular networks database, created by extraction of biological facts from the entire PubMed, and Seqware™ personal sequence data management platform. More on Ariadne Genomics please find at www.ariadnegenomics.com .
About Bayer HealthCare AG
Bayer HealthCare AG, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the health care and medical products industry. In 2004, the Bayer HealthCare subgroup generated sales amounting to some 8.5 billion Euro.
The company combines the global activities of the divisions Animal Health, Biological Products, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. Bayer HealthCare employed 35,300 people worldwide in 2004.
Bayer HealthCare’s aim is to discover and manufacture innovative products that will improve human and animal health worldwide. The products enhance well-being and quality of life by diagnosing, preventing and treating disease.
